Cokgor, I., Akabani, G., Friedman, A., Coleman, R. E., Zalutsky, M., McLendon, R. E., … Bigner, D. D. (1999). Phase I trial of newly diagnosed brain tumor patients treated with ¹³¹I-anti-tenascin MAb 81C6 via surgically created resection cavities. In NEUROLOGY (Vol. 52, pp. A245–A245).

Cokgor, I., G. Akabani, A. Friedman, R. E. Coleman, M. Zalutsky, R. E. McLendon, S. Bigner, et al. “Phase I trial of newly diagnosed brain tumor patients treated with ¹³¹I-anti-tenascin MAb 81C6 via surgically created resection cavities.” In NEUROLOGY, 52:A245–A245, 1999.

Cokgor I, Akabani G, Friedman A, Coleman RE, Zalutsky M, McLendon RE, et al. Phase I trial of newly diagnosed brain tumor patients treated with ¹³¹I-anti-tenascin MAb 81C6 via surgically created resection cavities. In: NEUROLOGY. 1999. p. A245–A245.

Cokgor, I., et al. “Phase I trial of newly diagnosed brain tumor patients treated with ¹³¹I-anti-tenascin MAb 81C6 via surgically created resection cavities.” NEUROLOGY, vol. 52, no. 6, 1999, pp. A245–A245.

Cokgor I, Akabani G, Friedman A, Coleman RE, Zalutsky M, McLendon RE, Bigner S, Xiao-Guang Z, Pegram C, Wikstrand C, Herndon J, Provenzale J, Friedman HS, Bigner DD. Phase I trial of newly diagnosed brain tumor patients treated with ¹³¹I-anti-tenascin MAb 81C6 via surgically created resection cavities. NEUROLOGY. 1999. p. A245–A245.